Mainz Biomed B.V. (MYNZ)
NASDAQ: MYNZ
· Real-Time Price · USD
1.76
0.07 (4.14%)
At close: Aug 15, 2025, 3:59 PM
1.69
-3.98%
After-hours: Aug 15, 2025, 05:30 PM EDT
Mainz Biomed B.V. Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
Cash & Equivalents | 6.24M | 977.76K | 7.07M | 10.91M | 17.14M | 26.01M | 8.73M | 195.16K |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | 108.00 | 106.00 | 23.27K | 11.53K | -431.59K | n/a |
Receivables | 213.75K | 139.41K | 354.51K | 370.93K | 63.74K | 59.03K | 17.2K | 74.54K |
Inventory | 372.87K | 520.53K | 613.64K | 387.18K | 175.47K | 36.69K | n/a | n/a |
Other Current Assets | n/a | 327.13K | 135.06K | n/a | 195.4K | 273.88K | n/a | n/a |
Total Current Assets | 7.84M | 2.39M | 8.98M | 12.13M | 18.38M | 26.8M | 9.61M | 281.61K |
Property-Plant & Equipment | 2.38M | 2.86M | 3.03M | 3.55M | 1.84M | 805.51K | 431.59K | 452.87K |
Goodwill & Intangibles | 3.02M | 3.21M | 3.39M | 3.63M | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 5.39M | 6.06M | 6.43M | 7.18M | 1.86M | 817.04K | 431.59K | 452.87K |
Total Assets | 13.24M | 8.45M | 15.41M | 19.31M | 20.24M | 27.62M | 10.04M | 734.47K |
Account Payables | 1.25M | 1.65M | 2.33M | 2.74M | 1.33M | 503.18K | 832.52K | 26.55K |
Deferred Revenue | n/a | n/a | 138.89K | n/a | 199.41K | n/a | n/a | 1.46K |
Short-Term Debt | 2.13M | 5.92M | 4.94M | 5.52M | 1.04M | 1M | 193.43K | n/a |
Other Current Liabilities | 690.58K | 440.68K | 388.84K | n/a | 199.41K | 104.84K | n/a | 606.15K |
Total Current Liabilities | 5.95M | 10.01M | 9.24M | 10.71M | 4.24M | 2.47M | 1.35M | 672.05K |
Long-Term Debt | n/a | 981.06K | 1.03M | 984.46K | 943.21K | 894.83K | 1.94M | 2.47M |
Other Long-Term Liabilities | 376.1K | 551.56K | 726.98K | 874.7K | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 1.24M | 2.58M | 2.92M | 3.42M | 1.9M | 1.37M | 2.33M | 2.47M |
Total Liabilities | 7.19M | 12.59M | 12.16M | 14.13M | 6.14M | 3.84M | 3.68M | 3.15M |
Total Debt | 3.27M | 8.27M | 7.42M | 8.53M | 3.23M | 2.49M | 2.58M | 2.7M |
Common Stock | 922.13K | 276.38K | 235.82K | 175.78K | 164.9K | 163.33K | 141.07K | 114.01K |
Retained Earnings | -90.98M | -80.35M | -69.33M | -57.84M | -43.03M | -29.25M | -16.64M | -5.22M |
Comprehensive Income | 27.04M | 21.8M | 20.83M | 19.63M | 18.13M | 14.6M | 9.74M | 2.69M |
Shareholders Equity | 6.05M | -4.14M | 3.25M | 5.18M | 14.1M | 23.77M | 6.36M | -2.41M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |